To include your compound in the COVID-19 Resource Center, submit it here.

Medix Products begins Phase III of obesity candidate

Medix Products S.A. de C.V. (Mexico City, Mexico) began a Phase III trial of tesofensine (NS2330) to treat

Read the full 187 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE